A Study of LY3039478 in Japanese Participants With Advanced Solid Tumors

Status:
Active, not recruiting

Trial end date:
2021-11-30

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the tolerability of the study drug LY3039478 in Japanese participants with advanced solid tumors.

Phase 1

Eli Lilly and Company